Andrew M. Griffin

602 citations

21 papers · 424 indexed · h-index 12

Co-authors: George M. Sheldrick W. A. Brown Timothy Gallagher Stephen Hanessian Daniel S. La Boyd L. Harrison Francesco G. Salituro María‐Jesús Blanco
Topics: Receptor Mechanisms and Signaling (4 papers)Neuropeptides and Animal Physiology (4 papers)Carbohydrate Chemistry and Synthesis (4 papers)
Cited by: Sensory Systems Cellular and Molecular Neuroscience Organic Chemistry
Journals: Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics Epilepsia
Partner nations: United States Canada United Kingdom

In The Last Decade

Andrew M. Griffin

21 papers receiving 406 citations

Peers

Countries citing papers authored by Andrew M. Griffin

Since Specialization

Citations

This map shows the geographic impact of Andrew M. Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Griffin more than expected).

Fields of papers citing papers by Andrew M. Griffin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew M. Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Griffin. The network helps show where Andrew M. Griffin may publish in the future.

Co-authorship network of co-authors of Andrew M. Griffin

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Griffin. A scholar is included among the top collaborators of Andrew M. Griffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Griffin. Andrew M. Griffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The novel persistent sodium current inhibitor PRAX‐562 has potent anticonvulsant activity with improved protective index relative to standard of care sodium channel blockers 2022 ·Epilepsia ·Kristopher M. Kahlig,(unknown),Robert J. Hatch,Andrew M. Griffin,(unknown),Zoë A. Hughes,Marion Wittmann	13
2	Discovery of the First Orally Available, Selective K_Na1.1 Inhibitor: In Vitro and In Vivo Activity of an Oxadiazole Series 2021 ·ACS Medicinal Chemistry Letters ·Andrew M. Griffin,Kristopher M. Kahlig,Robert J. Hatch,Zoë A. Hughes,Mark L. Chapman,Brett M. Antonio,Brian E. Marron,Marion Wittmann,Gabriel Martínez-Botella	24
3	Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 2020 ·Molecular Cancer Therapeutics ·(unknown),(unknown),(unknown),Kara M. Soroko,Benjamin K. Eschle,Margaret K. Wilkens,Prafulla C. Gokhale,Francis J. Giles,Andrew M. Griffin,(unknown),Geoffrey I. Shapiro,Beth E. Zucconi,Philip A. Cole,Madeleine E. Lemieux,Christopher A. French	58
4	Safety, Pharmacokinetics, and Pharmacodynamics Study in Healthy Subjects of Oral NEO6860, a Modality Selective Transient Receptor Potential Vanilloid Subtype 1 Antagonist 2017 ·Journal of Pain ·W. A. Brown,Richard L. Leff,Andrew M. Griffin,Stuart Hossack,(unknown),Philippe Walker,D. Chiche	42
5	Breakthroughs in neuroactive steroid drug discovery 2017 ·Bioorganic & Medicinal Chemistry Letters ·María‐Jesús Blanco,Daniel S. La,(unknown),(unknown),Andrew M. Griffin,Boyd L. Harrison,Francesco G. Salituro	40
6	Novel Methodology to Identify TRPV1 Antagonists Independent of Capsaicin Activation 2012 ·SLAS DISCOVERY ·(unknown),(unknown),Patricia LaPlante,Michael J. Morton,Karen L. Jones,Martin J. Main,(unknown),(unknown),Andrew M. Griffin,Jean Labrecque,Sultan Ahmad,W. A. Brown	10
7	Preclinical Pharmacology of AZD2327: A Highly Selective Agonist of the δ-Opioid Receptor 2011 ·Journal of Pharmacology and Experimental Therapeutics ·Thomas J. Hudzik,Carla Maciag,Mark A. Smith,Robert Caccese,(unknown),Khanh Bui,(unknown),(unknown),Kemal Payza,Andrew M. Griffin,Gennady Smagin,Dong‐Keun Song,Michael D.B. Swedberg,W. A. Brown	44
8	Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules 2011 ·Bioorganic & Medicinal Chemistry Letters ·Tim Luker,Lilian Alcaraz,Kamaldeep K. Chohan,Niklas Blomberg,Dearg S. Brown,Roger J. Butlin,Thomas Elebring,Andrew M. Griffin,Simon D. Guile,Stephen A. St-Gallay,Britt‐Marie Swahn,Steve Swallow,Michael J. Waring,Mark C. Wenlock,Paul D. Leeson	49
9	N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: The development of diaryl amino piperidines as potent δ opioid receptor agonists with in vivo anti-nociceptive activity in rodent models 2009 ·Bioorganic & Medicinal Chemistry Letters ·Paul A. Jones,Andrew M. Griffin,Lars Gawell,(unknown),Daniel Delorme,Edward Roberts,W. A. Brown,Christopher Walpole,(unknown),Jamie Boulet,Maryse Labarre,(unknown),Joanne Butterworth,Stéphane St-Onge,(unknown),(unknown)	12
10	Delta agonist hydroxy bioisosteres: The discovery of 3-((1-benzylpiperidin-4-yl){4-[(diethylamino)carbonyl]phenyl}amino)benzamide with improved delta agonist activity and in vitro metabolic stability 2009 ·Bioorganic & Medicinal Chemistry Letters ·Andrew M. Griffin,W. A. Brown,Christopher Walpole,(unknown),Lynda Adam,Mylène Gosselin,(unknown),(unknown),(unknown)	7
11	Penicillamine as a ligand in the catalytic asymmetric reduction of ketones 2002 ·Canadian Journal of Chemistry ·Stephen Hanessian,Eric Jnoff,Andrew M. Griffin	2
12	Asymmetric synthesis of functionalized carbocycles and heterocycles 2000 ·Chirality ·Stephen Hanessian,Andrew M. Griffin,Louis‐David Cantin	2
13	Synthesis of conformationally constrained potential inhibitors of mammalian metalloproteinases 1997 ·Bioorganic & Medicinal Chemistry Letters ·Stephen Hanessian,Andrew M. Griffin,Pratik Devasthale	9
14	Tricyclic β-lactams: Total synthesis and antibacterial activity of 5α-methoxyethyl and 5α-hydroxyethyl trinems 1997 ·Bioorganic & Medicinal Chemistry Letters ·Stephen Hanessian,Andrew M. Griffin,Michael J. Rozema	15
15	Carbohydrate building blocks in heterocyclic chemistry. Synthetic studies directed towards the herbicidins 1996 ·Pure and Applied Chemistry ·(unknown),Andrew M. Griffin,Timothy Gallagher	11
16	Reductive cleavage as a route to carbohydrate enolates. Applications to the synthesis of C-linked disaccharides 1995 ·Journal of the Chemical Society Chemical Communications ·(unknown),Andrew M. Griffin,(unknown),(unknown),Timothy Gallagher,Frieder W. Lichtenthaler	20
17	Chemistry of the herbicidins. Reactivity of silyl enol ethers derived from simple and carbohydrate-based tetrahydropyrans 1994 ·Journal of the Chemical Society Perkin Transactions 1 ·Paul Cox,Andrew M. Griffin,Nicholas J. Newcombe,Simon Lister,(unknown),David Alker,Timothy Gallagher	7
18	2-Keto Sugars as Preformed Heterocyclic Building Blocks. Synthetic Studies 1993 ·Heterocycles ·Timothy Gallagher,Andrew M. Griffin,Nicholas J. Newcombe,David Alker,(unknown)	6
19	Tetrasulphur tetranitride–bis(norbornadiene) 1975 ·Acta Crystallographica Section B ·Andrew M. Griffin,George M. Sheldrick	11
20	β-Tetraphosphorus pentasulphide 1975 ·Acta Crystallographica Section B ·Andrew M. Griffin,George M. Sheldrick	27

About Andrew M. Griffin

Andrew M. Griffin is a scholar working on Sensory Systems, Cellular and Molecular Neuroscience and Behavioral Neuroscience, having authored 21 papers that have together received 424 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (4 papers), Neuropeptides and Animal Physiology (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). The work is most often cited by research in Sensory Systems (36 citations), Cellular and Molecular Neuroscience (104 citations) and Organic Chemistry (124 citations). Andrew M. Griffin has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include George M. Sheldrick, W. A. Brown, Timothy Gallagher, Stephen Hanessian, Daniel S. La, Boyd L. Harrison, Francesco G. Salituro, María‐Jesús Blanco, Stuart Hossack and Richard L. Leff. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Epilepsia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact